Seagen building $400m WA manufacturing plant

URLhttps://bioprocessintl.com/bioprocess-insider/seag
Sourcehttps://bioprocessintl.com/
Date Published04/25/2022
Author NameDan Stanton
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Seagen
Parent companySeagen Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):200
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2024
Domestically, the work will be done:In-house
Capital investment ($):400
City reshored to:Everett,
State(s) reshored to:WA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredAntibody-drug conjugate
Find Reshoring Articles